Phase 2 Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to give your informed consent to take part in the trial
- Your kidney cancer has been confirmed by a tissue sample (biopsy) and is a specific type called clear-cell or sarcomatoid renal cell carcinoma
- Your cancer is at a certain stage or spread, as determined by your medical team after surgery (confirm with trial site for exact staging details)
- You have never had immunotherapy treatment for your kidney cancer before
- You are generally able to carry out daily activities with little to no limitation (confirm with trial site)
- You are 18 years of age or older
- You are of any ethnic or racial background
- Your kidneys and liver are functioning well enough, based on standard blood tests
- Your bone marrow is producing enough blood cells, based on standard blood tests
- If you are a woman who could become pregnant, or the female partner of a male participant, you must agree to use a reliable form of contraception during treatment and for at least 5 months after the last dose
Who may not be able to join:
- You have previously had radiation therapy or certain immunotherapy drugs (anti-PD1, anti-PDL1, or anti-CTLA-4) for kidney cancer
- You have an active or recent autoimmune disease, or have needed steroid or immune-suppressing medications for such a condition (some exceptions may apply — confirm with trial site)
- You have active lung inflammation (such as a condition called pneumonitis) or have had it in the past and needed steroid treatment
- Your blood oxygen level is below 92% while breathing normal room air
- You are currently using or plan to use probiotics, prebiotics, yogurt, bacteria-enriched foods, or similar supplements within 2 weeks before or during treatment
- You are currently taking steroid medications above a certain dose, or other immune-suppressing medicines, within 14 days before starting the trial (some exceptions may apply — confirm with trial site)
- You have uncontrolled adrenal gland problems
- You have a medical condition — such as ongoing diarrhoea or a bowel condition — that the trial doctor believes could make participation unsafe or affect results
- You still have significant side effects from any previous treatment that have not yet resolved
- You are currently pregnant or breastfeeding
- You have a history of heart muscle inflammation, serious heart failure, unstable chest pain, serious uncontrolled heart rhythm problems, uncontrolled infection, or a heart attack within the past 6 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in interleukin (IL)-12 levels
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.